| Financial Year |
March 31 2023 |
| Monetary Funds |
911,112,435.00 |
| Held-for-trading Financial Assets |
593,065,240.32 |
| Notes Receivable |
1,400,796.72 |
| Accounts Receivable |
969,880,833.18 |
| Advances to Suppliers |
25,818,855.67 |
| Other Receivables |
46,856,172.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
42,487,819.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
25,520,854.43 |
| Total Current Assets |
2,622,258,349.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,094,257,776.79 |
| Under-construction Projects |
161,593,580.50 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
116,920,962.07 |
| R&D expenses |
-- |
| Goodwill |
64,132,048.13 |
| Long-Term Deferred and Prepaid Expenses |
107,092,157.38 |
| Deferred Income Tax Assets |
49,772,748.26 |
| Other Non-Current Assets |
118,640,580.89 |
| Sub-Total of Non-Current Assets |
1,846,501,384.31 |
| Total Assets |
4,468,759,733.86 |
| Short-Term Loans |
86,760,002.63 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
203,829,957.37 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
89,377,052.47 |
| Taxes Payable |
37,164,609.06 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
95,742,492.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
40,340,084.61 |
| Other Current Liabilities |
8,917,605.52 |
| Sub-Total of Current Liabilities |
749,927,156.42 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
34,503,411.08 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
149,180,604.76 |
| Total Liabilities |
899,107,761.18 |
| Paid-In Capital(Or Share Stock) |
287,013,456.00 |
| Capital Surplus |
1,839,003,113.98 |
| Surplus Reserve |
50,725,253.09 |
| LESS:Treasury Stock |
6,446,535.99 |
| Undistributed Profits |
1,386,433,768.11 |
| Minority Stockholder's Interest |
12,914,316.33 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,556,737,656.35 |
| Owner's Equity（Stockholder's Equity） |
3,569,651,972.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,468,759,733.86 |
